Cargando…
Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment
SIMPLE SUMMARY: β-thalassemia syndromes are clinically and genetically heterogeneous blood disorders presented by β-chain deficiency in hemoglobin production. Despite improvements in transfusion practices and chelation treatment, many lingering challenges have encouraged researchers to develop newer...
Autores principales: | Rahimmanesh, Ilnaz, Boshtam, Maryam, Kouhpayeh, Shirin, Khanahmad, Hossein, Dabiri, Arezou, Ahangarzadeh, Shahrzad, Esmaeili, Yasaman, Bidram, Elham, Vaseghi, Golnaz, Haghjooy Javanmard, Shaghayegh, Shariati, Laleh, Zarrabi, Ali, Varma, Rajender S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219845/ https://www.ncbi.nlm.nih.gov/pubmed/35741383 http://dx.doi.org/10.3390/biology11060862 |
Ejemplares similares
-
Cancer Occurrence as the Upcoming Complications of COVID-19
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022) -
Crosstalk of Transcriptional Regulators of Adaptive Immune System and microRNAs: An Insight into Differentiation and Development
por: Boshtam, Maryam, et al.
Publicado: (2023) -
The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution
por: Khanahmad, Negar, et al.
Publicado: (2020) -
The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
por: Kouhpayeh, Shirin, et al.
Publicado: (2021) -
Construction and characterization of human embryonic kidney-(HEK)-293T cell overexpressing truncated α4 integrin
por: Fatahi, Azam, et al.
Publicado: (2018)